Beta
Back to CRNC.US Analysis

Ticker

Value

empty

There is no following symbol in this watchlist.

  • Revenue by Segments
  • EPS
  • EPS Diluted
  • Revenue
  • Operation Income
  • Net Income
  • Operating Expenses
  • Cash Flow
  • Cash & Debt
  • Current Contract Liabilities
operating-expenses-chart

CRNC Operating Expenses

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

In Q1'26, Cerence's (CRNC) total operating expenses reached $62.2M USD, comprising $24.7M in R&D expenses and $37.5M in SG&A expenses. This marks a slight decline in R&D from $26.4M in Q4'25 but a significant 101% surge in SG&A from $18.7M in the prior quarter, driving the overall total up 5% quarter-over-quarter. Over the period from Q2'23 to Q1'26, operating expenses exhibited an initial upward trend in R&D, peaking at $35.1M in Q4'23 before steadily declining to $24.7M amid cost optimization efforts, while SG&A fluctuated between $15M and $27.3M with notable volatility, including a sharp drop to $15M in Q3'24 and a recent spike in Q1'26. Total expenses trended downward overall from a high of $52.4M in Q2'23 to $43.3M in Q3'25, reflecting improved efficiency, though the latest quarter's SG&A increase signals potential pressures from administrative or expansion activities.